Peer Revier Process

Peer Review Process
Double-blind • ≥2 reviewers • Transparent timeline

IONTech implements a double-blind peer review (both author and reviewer identities are concealed). Each manuscript is evaluated by at least two reviewers.

Workflow & Stages
  1. Submission – Authors upload manuscripts using the provided template & author statement.
  2. Initial Check (3–5 days) – Editor checks scope, completeness, format, and similarity (≤ 25%; references & quotations automatically excluded).
  3. Assignment – Editor assigns a Section Editor and recommends ≥2 reviewers.
  4. Review Round 1 (14 days) – Reviewers evaluate the manuscript and provide recommendations: Accept / Minor / Major / Reject.
  5. Editor’s Decision – Consolidating reviewers’ feedback and issuing a decision.
  6. Author Revision
    • Minor: ≤ 7–10 days • Major: ≤ 14–21 days
  7. Re-review (if required) – Re-evaluation by the same reviewer(s).
  8. Copyediting & Proofreading (5–7 days) – Language, citation style, tables/figures.
  9. Layout & Galley (3–5 days) – Finalization of PDF/HTML and metadata.
  10. Publication – Articles are published in scheduled issues and indexed.
Target Timeline (SLA)
Stage Duration
Screening & Similarity Check 3–5 days
Round 1 Review (per reviewer) 14 days
Author Revision (minor/major) 7–10 / 14–21 days
Copyediting + Layout 8–12 days
Evaluation Criteria
Aspect Description Score (1–5)
Novelty & Contribution Originality of the topic, significance of findings 1–5
Methodology Design, validity, statistical analysis 1–5
Literature Review Adequacy & currency of references 1–5
Clarity of Presentation Structure, language, tables/figures 1–5
Ethics & Feasibility Ethical approval, safety, COI, data 1–5
Scale: 1 = Poor • 2 = Fair • 3 = Average • 4 = Good • 5 = Excellent
Decision
  • Accept – accepted with/without minor editorial changes.
  • Minor Revision – small corrections; no re-testing required.
  • Major Revision – substantial revisions; may require re-review.
  • Reject – out of scope / insufficient quality / ethical issues.
Ethics Policy
  • Plagiarism: manuscripts with similarity index > 25% will be rejected at the initial stage.
  • COI: Authors & reviewers must declare any conflict of interest.
  • Confidentiality: All manuscripts & review data are strictly confidential.
  • Appeals: Authors may submit a written appeal to the Editor-in-Chief with supporting evidence.
Ethics reference: COPE